angiotensin ii has been researched along with valyl-prolyl-proline in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braun, WH; Dent, MP; Marburger, A; O'Hagan, S; Schaetti, P; Vogel, O | 1 |
| Ajisaka, R; Choi, Y; Maeda, S; Misono, M; Miyaki, A; Shimojo, N; Tanaka, H; Yoshizawa, M | 1 |
| Lv, M; Song, T; Sun, B; Zhao, M; Zheng, L | 1 |
| Huang, M; Lv, M; Song, G; Song, T; Zhang, L; Zhang, X; Zhao, M; Zheng, L | 1 |
1 trial(s) available for angiotensin ii and valyl-prolyl-proline
| Article | Year |
|---|---|
Additive beneficial effects of lactotripeptides and aerobic exercise on arterial compliance in postmenopausal women.
Topics: Administration, Oral; Aged; Angiotensin II; Blood Pressure; Brachial Artery; Carotid Arteries; Compliance; Cultured Milk Products; Dietary Supplements; Exercise; Female; Humans; Middle Aged; Oligopeptides; Oxygen Consumption; Postmenopause; Tablets; Ultrasonography | 2009 |
3 other study(ies) available for angiotensin ii and valyl-prolyl-proline
| Article | Year |
|---|---|
A 90-day subchronic toxicity study and reproductive toxicity studies on ACE-inhibiting lactotripeptide.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Blood Glucose; Chlorides; Cholesterol; Female; Fetal Development; Kidney; Male; Oligopeptides; Potassium; Rabbits; Random Allocation; Rats; Rats, Wistar; Reproduction; Sodium; Specific Pathogen-Free Organisms; Statistics, Nonparametric; Toxicity Tests, Chronic | 2007 |
Tripeptides Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP) Regulate the Proliferation and Migration of Vascular Smooth Muscle Cells by Interfering Ang II-Induced Human Umbilical Vein Endothelial Cells Derived EVs Delivering RNAs to VSMCs in the Co-culture Model.
Topics: Angiotensin II; Antihypertensive Agents; Cell Movement; Cell Proliferation; Coculture Techniques; Extracellular Vesicles; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Myocytes, Smooth Muscle; Oligopeptides; RNA | 2020 |
The Protective Effects of Tripeptides VPP and IPP against Small Extracellular Vesicles from Angiotensin II-Induced Vascular Smooth Muscle Cells Mediating Endothelial Dysfunction in Human Umbilical Vein Endothelial Cells.
Topics: Angiotensin II; Extracellular Vesicles; Human Umbilical Vein Endothelial Cells; Humans; Muscle, Smooth, Vascular; Oligopeptides; U937 Cells | 2020 |